What Bon Secours’ 10-year partnership with Philips hopes to achieve

The latest stories trending on MedCity News.

Editor's Pick

Top Story What Bon Secours' 10-Year Partnership with Philips Hopes to Achieve A 10-year partnership between the two organization will standardize patient monitoring hardware and software across 49 Bon Secours Mercy Health hospitals. Sponsored Save 30% and the HLTH 2024 Preliminary Agenda Revealed! Presented by HLTH Whether you're into cutting-edge health tech, passionate about policy shifts in healthcare, or just love a good debate on digital health, the HLTH 2024 agenda has got you covered. View the Preliminary Agenda Engage in Thought-Provoking Conversations at INVEST Digital Health Do you want to collaborate with like-minded professionals and innovators who share your passion for driving change in healthcare? Then INVEST Digital Health conference in Dallas is for you! Secure your ticket today to be part of a vibrant community shaping the future of healthcare.  See you there, September 18 at Pegasus Park! Grab Your Ticket Now, Save $100

Featured News

Headway Secures $100M To Expand to MA/Medicaid Members Headway's $100 million Series D funding round was led by Spark Capital and included participation from Thrive Capital, Accel, a16z and Forerunner Ventures. Electronic Quality Reporting Window Closing on MSSP ACOs: Time for Action Is Now The good news is that many ACOs have already made the transition to eCQM reporting. Proven best practices are now available. Savvy ACOs will capitalize on efforts to optimize broader quality initiatives under value-based payment over time. Fueled With $100M, Autobahn Therapeutics Gears Up for Depression Drug Clinical Trials Autobahn Therapeutics' platform technology enables small molecules to selectively hit targets in the brain. In addition to a lead program ready for Phase 2 testing in two types of depression, the startup has a preclinical molecule with potential applications in neuroinflammatory disorders such as multiple sclerosis. The Endovascular Revolution: Democratizing Access to Lifesaving Technology Access to minimally invasive treatment of complex vascular conditions is still limited worldwide. Bringing endovascular robots to ORs and healthcare facilities worldwide is key to improving stroke prevention and treatment and reducing the morbidity and financial burden of stroke and other life-threatening vascular conditions. To Give Rare Disease Patients Hope, the FDA Must Re-Focus its Efforts To bring cross-agency clinical leaders together, the FDA should establish a Center of Excellence for Rare Diseases. This would bring together specialized staff and resources from multiple review divisions to leverage their expertise about different bodily systems, trial designs, pharmacology, and other specialized fields.

Resources

AI in Healthcare: The Next Chapter The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe